Detalhe da pesquisa
1.
Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.
Muscle Nerve
; 68(5): 762-766, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37695277
2.
Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy.
Hum Mutat
; 43(4): 511-528, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35165973
3.
Patient preference for virtual versus in-person visits in neuromuscular clinical practice.
Muscle Nerve
; 66(2): 142-147, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35596667
4.
Would glucocorticoids be approved for clinical use if discovered today?
Muscle Nerve
; 2024 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38720486
5.
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift.
Eur J Neurol
; 30(12): 3644-3645, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37578121
6.
Therapeutic Plasma Exchange Versus FcRn Inhibition in Autoimmune Disease.
Transfus Med Rev
; 38(1): 150767, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37867088
7.
Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National Datasets
Neurology
; 102(2): e207863, 2024 01 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38165317
8.
Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study.
PLoS One
; 19(5): e0303053, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38776297
9.
A Multidisciplinary Assessment of ChatGPT's Knowledge of Amyloidosis: Observational Study.
JMIR Cardio
; 8: e53421, 2024 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38640472
10.
Guillain-Barré Syndrome.
Continuum (Minneap Minn)
; 29(5): 1327-1356, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37851033
11.
Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
Neurol Ther
; 12(5): 1573-1590, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37166675
12.
A Novel Ergonomic Curette Design Reduces Dental Prophylaxis-Induced Muscle Work and Fatigue.
Dent J (Basel)
; 11(12)2023 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38132410
13.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Lancet Neurol
; 22(5): 383-394, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37059507
14.
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.
Neurology
; 101(10): 442-451, 2023 09 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37076302
15.
Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs.
Front Public Health
; 11: 1147489, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37275500
16.
Primary lateral sclerosis natural history study - planning, designing, and early enrollment.
Amyotroph Lateral Scler Frontotemporal Degener
; 24(5-6): 394-404, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36576200
17.
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease.
Neurology
; 2022 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35545446
18.
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study.
Neurotherapeutics
; 18(2): 1127-1136, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33624184
19.
Therapeutic strategies for diabetic neuropathy.
Curr Neurol Neurosci Rep
; 10(2): 92-100, 2010 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20425233
20.
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
JAMA Neurol
; 77(5): 582-592, 2020 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32065623